What are the major factors driving the growth of the in vitro fertilization (IVF) hormones market?

In Vitro Fertilization (IVF) Hormones Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037. Read More

What would be the CAGR of in vitro fertilization (IVF) hormones Market over the forecast period?

Increasing incidences of infertility worldwide, and the need amongst individuals to opt for IVF treatments, will impel the market growth.. Read More

Which region will provide more business opportunities for growth of in vitro fertilization (IVF) hormones market in future?

The major players in the market are Merck KGaA (OTCMKTS: MKKGY), GENPHARM, Aquatic Group, BioVendor â€“ Laboratorni medicina a.s., Biogenix Inc. Pvt. Ltd., and others. Read More

In Vitro Fertilization (IVF) Hormones Market Trends

Growth Drivers

Growing Concern for the Rising Infertility Rate Among Individuals to Propel the Growth of the Market

According to the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility amongst the US women of reproductive age, affecting as many as 5 million individuals (6% to 12% of US women of reproductive age).

One of the major causes of infertility in women is due to the occurrence of polycystic ovary syndrome (PCOS), which is linked to being overweight or having a family history of type 2 diabetes or PCOS. Rising awareness for infertility treatment, owing to the increasing incidences of infertility, rising cases of PCOS, and the growing number of couples who defer childbearing, are some of the factors anticipated to drive the demand for the use of IVF hormones, and in turn, drive the in vitro fertilization (IVF) hormones market growth. Moreover, increasing advancements in the field of IVF treatments, along with the growing success rate of IVF treatments are some of the additional factors anticipated to drive the growth of the IVF hormones market in the coming years.

Challenges

High Cost of IVF Treatment and Health Risks Associated with the utilization of IVF Hormones to Hamper the Market Growth

With numerous advantages associated with in vitro fertilization treatment procedures, there also lies numerous disadvantages, that are anticipated to hamper the market growth. One of the primary challenges associated with the growth of the market is the high cost of IVF treatment, which directly affects the demand for IVF hormones. Alternatively, the concern for risk of multiple births upon the use of these hormones, along with the severe reactions caused by the fertility drugs, such as ovarian hyperstimulation syndrome, and the social barriers present in several under-developed and developing nations for adopting IVF treatment, are some of the major factors anticipated to lower the market growth in the coming years.

In Vitro Fertilization (IVF) Hormones Market: Key Insights

Get more information on this report: Download Sample PDF

In vitro fertilization (IVF) is referred to the process of human reproduction where eggs from a woman’s ovaries are harvested and then fertilized in an artificial setting, and later implanted back into the uterus of the woman. This form of assisted reproductive technology (ART) solves problems related to infertility among both men and women. IVF hormones are referred to the fertility drugs that are given to men to produce sperms in case of male factor infertility, and in women to boost egg production, which further helps the women to achieve pregnancy through the process of IVF.

Base Year

2024

Forecast Year

2025-2037

Regional Scope

North America (U.S., and Canada)
Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Which region accounted for the largest IVF hormones industry share?

Europe industry is likely to hold largest revenue share by 2037, backed by increasing adoption of IVF procedures amongst individuals, and increasing support of the government for raising awareness for IVF treatments.

In Vitro Fertilization (IVF) Hormones Market Trends